Senior Member & Professor
Chair, Department of Malignant Hematology
Moffitt Cancer Center
Director, Clinical and Translational Leukemia Programs
Professor of Medicine
Weill Cornell Medicine
The New York Presbyterian Hospital
New York, New York
Professor of Oncology
Division of Hematologic Malignancies
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Associate Member, Clinical Research Division
Fred Hutchinson Cancer Research Center
Associate Professor of Medicine
Division of Hematology
Department of Medicine
University of Washington School of Medicine
Adjunct Associate Professor
Department of Epidemiology
University of Washington School of Public Health
Associate Managing Editor
Editorial Director, Hematology/Oncology
Senior Managing Editor
This program is intended for physicians and other healthcare providers who care for patients with acute myeloid leukemia.
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Clinical Care Options, LLC. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 3.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This program has been made available online.
Participation in this self-study activity should be completed in approximately 3.25 hours. To successfully complete this activity and receive credit, participants must follow these steps during the period from January 31, 2018, through January 30, 2019:
1. Register online at http://www.clinicaloptions.com.
2. Read the target audience, learning objectives, and faculty disclosures.
3. Study the educational activity online or printed out.
4. Submit answers to the posttest questions and evaluation questions online.
You must receive a test score of at least 70% and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the posttest confirmation page. Records of all CME activities completed can be found on the "CME Manager" page. There are no costs/fees for this activity.
In this CME-certified activity, Farhad Ravandi, MD, explores optimal current treatment of this rare leukemia, including standard systemic therapies and targeted approaches, as well as emerging therapies.
In this downloadable slideset from the CME-certified hairy cell leukemia activity, Farhad Ravandi, MD, provides expert perspective on selecting optimal treatment strategies and promising therapies for your patients with HCL.
Without comparative data to guide us, how do we decide between recommending ibrutinib or acalabrutinib? Here’s my take on which factors to consider in your patients with CLL or MCL.
In this expert analysis, John M. Burke, MD, and Christopher R. Flowers, MD, review and provide their perspective on key lymphomas and CLL studies presented at the Hematology 2017 annual meeting.
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.